查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726195

脂质奈米颗粒市场规模、份额、趋势分析报告：按脂质奈米颗粒、分子、应用、适应症、最终用途、地区、细分市场、预测，2025-2030 年

Lipid Nanoparticle Market Size, Share & Trends Analysis Report By LNP (Liposomes, Nanostructured Lipid Carriers), By Molecule (mRNA, siRNA), By Application, By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

脂质奈米颗粒市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球脂质奈米颗粒市场预计到 2030 年将达到 15.4 亿美元，预测期内的复合年增长率为 13.64%。

由于对先进药物传递系统的需求不断增加，脂质市场正在经历显着增长，尤其是在基因治疗、肿瘤学和疫苗等领域。 LNP 描述了一种高效方法，可以封装和递送多种治疗分子（包括 mRNA、siRNA 和小分子），将其直接递送至目标细胞，同时提高稳定性并减少降解。公共和私人公司对奈米医学的研发活动激增和投资不断增加，在支持製药和生物技术领域广泛采用基于 LNP 的药物製剂方面发挥关键作用。

在疫情期间，利用基于 LNP 的 mRNA 疫苗递送系统开发 COVID-19 疫苗引起了大量关注和资源。人们对疫苗输送技术的日益关注推动了 LNP 配方和製造能力的创新和投资，间接使市场受益。监管机构加快了 COVID-19 治疗和疫苗的审查和核准流程，其中包括利用 LNP 技术的治疗和疫苗。虽然这促进了 COVID-19 治疗药物的快速进入市场，但也凸显了简化其他治疗领域基于 LNP 的产品的监管途径和标准的必要性，这可能会影响未来的法律规范和市场动态。

此外，策略合作、脂质製剂的技术进步以及对精准医疗的认识不断提高继续推动市场成长。该公司目前正在投资下一代 LNP 平台，旨在实现定向投放、降低毒性并提高有效载荷的多功能性。可电离脂质、脂质-聚合物混合系统和表面改质等创新正在扩大 LNP 在治疗复杂疾病（包括罕见遗传疾病）方面的范围。这些发展，加上有利的监管环境和日益增长的个人化治疗需求，预计将在未来几年保持强劲的市场势头。

脂质奈米颗粒市场报告重点

  • 以 LNP 计算，脂质体领域在 2024 年占据了整个市场的主导地位，收益占有率最大。脂质体药物的监管核准及其在化妆品和营养保健品应用中的不断扩大，继续支持市场成长。
  • 以分子计算，mRNA 部分预计将在 2024 年占据整个市场的最大收益占有率，并在预测期内以最快的复合年增长率增长。随着製药和生物技术公司增加对 mRNA 疗法的投资，对优化 LNP 输送系统的需求持续上升，从而推动市场成长。
  • 2024年，医疗应用领域占据主导地位。这是由于研究机构和工业参与企业在药物开发方面的合作增加，以及政府资金增加。
  • 预计到 2024 年，肿瘤学将占据适应症领域的主导地位，并在预测期内实现显着的复合年增长率。癌症负担的不断加重以及 LNP 在癌症治疗中的潜力正在推动该领域的重大研究和发展。
  • 预计製药和生物技术公司将主导最终用途领域，而学术和研究机构领域预计将在预测期内实现最快的复合年增长率。
  • 由于感染疾病负担高、购买力平价高、政府对优质医疗的支持以及报销的可用性等因素，北美将在 2024 年占据市场主导地位。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 依因素（政治/法律、经济/技术）进行 SWOT 分析
    • 波特五力分析
    • COVID-19影响分析

4. 脂质奈米颗粒市场：LNP 业务分析

  • 细分仪表板
  • 脂质奈米粒子的全域变异性分析
  • 全球脂质奈米颗粒市场规模与趋势分析（LNP，2018-2030）
  • 脂质体
  • 固体脂质奈米颗粒
  • 奈米结构脂质载体
  • 其他的

5. 脂质奈米颗粒市场：分子业务分析

  • 细分仪表板
  • 脂质奈米粒子的全域变异性分析
  • 全球脂质奈米颗粒市场规模及趋势分析（按分子，2018-2030 年）
  • siRNA
  • mRNA
  • 其他的

6. 脂质奈米颗粒市场：应用商业分析

  • 细分仪表板
  • 脂质奈米粒子的全域变异性分析
  • 全球脂质奈米颗粒市场规模及趋势分析（依应用，2018-2030）
  • 治疗
  • 研究

7. 脂质奈米颗粒市场：适应症业务分析

  • 细分仪表板
  • 脂质奈米粒子的全域变异性分析
  • 全球脂质奈米颗粒市场规模及趋势分析（2018-2030）
  • 癌症
  • 感染疾病
  • 血液系统疾病
  • 其他的

8. 脂质奈米颗粒市场-最终用途业务分析

  • 细分仪表板
  • 脂质奈米粒子的全域变异性分析
  • 全球脂质奈米颗粒市场规模及最终用途趋势分析（2018-2030）
  • 製药和生物技术公司
  • 学术研究所
  • 其他的

第九章脂质奈米颗粒市场：LNP、分子、应用、适应症、最终用途、区域、估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测与趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024年公司地位分析
  • 公司简介/上市公司
    • Merck KGaA
    • Evonik Industries AG
    • Gattefosse
    • FUJIFILM Pharmaceutical
    • Danaher（Precision NanoSystems）
    • Creative Biolabs
    • IOI Oleo GmbH
    • NOF Corporation
    • Lipoid GmbH
    • Cyman Chemical
Product Code: GVR-4-68040-547-5

Lipid Nanoparticle Market Growth & Trends:

The global lipid nanoparticle market is anticipated to reach USD 1.54 billion by 2030 and is projected to grow at a CAGR of 13.64% during the forecast period, according to a new report by Grand View Research, Inc. The lipid market has experienced significant growth driven by increasing demand for advanced drug delivery systems, particularly in the fields of gene therapy, oncology, and vaccines. LNPs offer a highly efficient method for encapsulating and delivering a wide range of therapeutic molecules-including mRNA, siRNA, and small molecules-directly to target cells with improved stability and reduced degradation. The surge in R&D activities and growing investment in nanomedicine by both public institutions and private players have played a critical role in supporting the widespread adoption of LNP-based drug formulations across the pharmaceutical and biotechnology sectors.

The development of COVID-19 vaccines that utilized LNP-based delivery systems for mRNA vaccines garnered significant attention and resources during the pandemic. This increased focus on vaccine delivery technologies has indirectly benefited the market by driving innovation and investment in LNP formulation and manufacturing capabilities. Regulatory agencies expedited the review and approval processes for COVID-19 therapeutics and vaccines, including those utilizing LNP technology. While this facilitated rapid market entry for COVID-19 treatments, it also underscored the need for streamlined regulatory pathways and standards for LNP-based products in other therapeutic areas, potentially shaping future regulatory frameworks and market dynamics.

Moreover, strategic collaborations, technological advancements in lipid formulation, and increased awareness of precision medicine continue to drive market growth. Companies are now investing in next-generation LNP platforms designed for targeted delivery, lower toxicity, and enhanced payload versatility. Innovations such as ionizable lipids, hybrid lipid-polymer systems, and surface modifications are expanding the scope of LNPs in treating complex diseases, including rare genetic disorders. These developments, coupled with a favorable regulatory landscape and rising demand for personalized treatments, are expected to sustain strong momentum in the market over the coming years.

Lipid Nanoparticle Market Report Highlights:

  • Based on LNP, the liposomes segment dominated the overall market with the largest revenue share in 2024. Regulatory approvals of liposome-based drugs and their expanding use in cosmetic and nutraceutical applications continue to support market growth.
  • In terms of molecule, the mRNA segment dominated the overall market with the largest revenue share in 2024 and is expected to grow at the fastest CAGR during the forecast period. As pharmaceutical companies and biotech firms increasingly invest in mRNA therapeutics, the demand for optimized LNP delivery systems continues to rise, fueling market growth.
  • Therapeutics dominated the application segment in 2024 owing to the increasing collaborations between research institutions and industry players for drug development and growing government funding,
  • In 2024, cancer dominated the disease indication segment and is expected to witness a significant CAGR over the forecast period. The rising cancer burden and the potential of LNPs in cancer treatment are driving significant research and development efforts in this area.
  • Pharmaceutical & biotechnology companies dominated the end use segment and the academic & research institute segment is expected to register the fastest CAGR during the forecast period.
  • North America dominated the market in 2024 owing to factors such as the significant burden of infectious diseases, high purchasing power parity, government support for quality healthcare, and availability of reimbursement.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. LNP
    • 1.2.2. Molecule
    • 1.2.3. Application
    • 1.2.4. Indication
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Growing Demand for Drug Delivery Systems
      • 3.3.1.2. Rise in Pharmaceutical Research and Development
      • 3.3.1.3. Increasing Focus on Nanotechnology
      • 3.3.1.4. Government Support and Funding for RNA-based therapies
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High Development Costs
      • 3.3.2.2. Stringent Regulations Related to Approval and Commercialization
  • 3.4. Industry Analysis Tools
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Lipid Nanoparticle Market: LNP Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Lipid Nanoparticle Movement Analysis
  • 4.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by LNP, 2018 to 2030 (USD Million)
  • 4.4. Liposomes
    • 4.4.1. Global Liposomes Market, 2018 - 2030 (USD Million)
  • 4.5. Solid Lipid Nanoparticles
    • 4.5.1. Global Solid Lipid Nanoparticles Market, 2018 - 2030 (USD Million)
  • 4.6. Nanostructured Lipid Carriers
    • 4.6.1. Global Nanostructured Lipid Carriers Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 5. Lipid Nanoparticle Market: Molecule Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Lipid Nanoparticle Movement Analysis
  • 5.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
  • 5.4. siRNA
    • 5.4.1. Global siRNA Market, 2018 - 2030 (USD Million)
  • 5.5. mRNA
    • 5.5.1. Global mRNA Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 6. Lipid Nanoparticle Market: Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Lipid Nanoparticle Movement Analysis
  • 6.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Therapeutics
    • 6.4.1. Global Therapeutics Market, 2018 - 2030 (USD Million)
  • 6.5. Research
    • 6.5.1. Global Research Market, 2018 - 2030 (USD Million)

Chapter 7. Lipid Nanoparticle Market: Indication Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Lipid Nanoparticle Movement Analysis
  • 7.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 7.4. Cancer
    • 7.4.1. Global Cancer Market, 2018 - 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Global Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 7.6. Blood Diseases
    • 7.6.1. Global Blood Diseases Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 8. Lipid Nanoparticle Market: End Use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Lipid Nanoparticle Movement Analysis
  • 8.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.5. Academic & Research Institutes
    • 8.5.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 9. Lipid Nanoparticle Market: Regional Estimates & Trend Analysis by LNP, Molecule, Application, Indication, & End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Target Disease Prevalence
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. U.S. Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Target Disease Prevalence
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Canada Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Target Disease Prevalence
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Mexico Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Target Disease Prevalence
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. UK Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Target Disease Prevalence
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Germany Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Target Disease Prevalence
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. France Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Target Disease Prevalence
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Italy Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Target Disease Prevalence
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Spain Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Target Disease Prevalence
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Denmark Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Target Disease Prevalence
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Sweden Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Target Disease Prevalence
      • 9.4.9.4. Regulatory Framework
      • 9.4.9.5. Norway Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Target Disease Prevalence
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Japan Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Target Disease Prevalence
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. China Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Target Disease Prevalence
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. India Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Target Disease Prevalence
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Australia Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Target Disease Prevalence
      • 9.5.6.4. Regulatory Framework
      • 9.5.6.5. Thailand Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Target Disease Prevalence
      • 9.5.7.4. Regulatory Framework
      • 9.5.7.5. South Korea Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Target Disease Prevalence
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Brazil Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Target Disease Prevalence
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Argentina Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Target Disease Prevalence
      • 9.7.2.4. Regulatory Framework
      • 9.7.2.5. South Africa Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Target Disease Prevalence
      • 9.7.3.4. Regulatory Framework
      • 9.7.3.5. Saudi Arabia Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Target Disease Prevalence
      • 9.7.4.4. Regulatory Framework
      • 9.7.4.5. UAE Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Target Disease Prevalence
      • 9.7.5.4. Regulatory Framework
      • 9.7.5.5. Kuwait Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Merck KGaA
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Evonik Industries AG
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Gattefosse
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. FUJIFILM Pharmaceutical
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. Danaher (Precision NanoSystems)
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Creative Biolabs
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. IOI Oleo GmbH
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. NOF Corporation
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Lipoid GmbH
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Cyman Chemical
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 4 Global lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 6 Global lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 7 Global lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Global lipid nanoparticle market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 11 North America lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 13 North America lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 14 North America lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 15 U.S. lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 16 U.S. lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 17 U.S. lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 18 U.S. lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 19 U.S. lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Canada lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 21 Canada lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 22 Canada lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 23 Canada lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Canada lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Mexico lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 26 Mexico lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 27 Mexico lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 28 Mexico lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Mexico lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Europe lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 31 Europe lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 32 Europe lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 33 Europe lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 34 Europe lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 35 Europe lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 36 UK lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 37 UK lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 38 UK lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 39 UK lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 40 UK lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Germany lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 42 Germany lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 43 Germany lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 44 Germany lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 45 Germany lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 46 France lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 47 France lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 48 France lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 49 France lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 50 France lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Italy lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 52 Italy lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 53 Italy lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 54 Italy lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 55 Italy lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Spain lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 57 Spain lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 58 Spain lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 59 Spain lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 60 Spain lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Denmark lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 62 Denmark lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 63 Denmark lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 64 Denmark lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 65 Denmark lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Sweden lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 67 Sweden lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 68 Sweden lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 69 Sweden lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 70 Sweden lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Norway lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 72 Norway lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 73 Norway lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 74 Norway lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Norway lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Japan lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 83 Japan lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 84 Japan lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 85 Japan lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 86 Japan lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 87 China lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 88 China lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 89 China lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 90 China lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 91 China lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 92 India lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 93 India lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 94 India lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 95 India lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 96 India lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Australia lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 98 Australia lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 99 Australia lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 100 Australia lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 101 Australia lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Thailand lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 103 Thailand lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 104 Thailand lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 105 Thailand lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 106 Thailand lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 107 South Korea lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 108 South Korea lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 109 South Korea lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 110 South Korea lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 111 South Korea lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Latin America lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 113 Latin America lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 114 Latin America lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 115 Latin America lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 116 Latin America lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 117 Latin America lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Brazil lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 119 Brazil lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 120 Brazil lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 121 Brazil lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 122 Brazil lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Argentina lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 124 Argentina lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 125 Argentina lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 126 Argentina lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 127 Argentina lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 134 South Africa lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 135 South Africa lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 136 South Africa lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 137 South Africa lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 138 South Africa lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 144 UAE lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 145 UAE lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 146 UAE lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 147 UAE lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 148 UAE lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 150 Kuwait lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 151 Kuwait lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 152 Kuwait lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 153 Kuwait lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products
  • Table 160 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Lipid nanoparticle market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Genomics - Industry value chain analysis
  • Fig. 15 Lipid nanoparticle market driver analysis
  • Fig. 16 Lipid nanoparticle market restraint analysis
  • Fig. 17 Lipid nanoparticle market: Porter's analysis
  • Fig. 18 Lipid nanoparticle market: LNP outlook and key takeaways
  • Fig. 19 Lipid nanoparticle market: LNP market share analysis, 2023 - 2030
  • Fig. 20 Global lipid nanoparticle by liposomes market, 2018 - 2030 (USD Million)
  • Fig. 21 Global lipid nanoparticle by solid lipid nanoparticles market, 2018 - 2030 (USD Million)
  • Fig. 22 Global lipid nanoparticle by nanostructured lipid carriers market, 2018 - 2030 (USD Million)
  • Fig. 23 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
  • Fig. 24 Lipid nanoparticle market: Molecule outlook and key takeaways
  • Fig. 25 Lipid nanoparticle market: Molecule market share analysis, 2023-2030
  • Fig. 26 Global lipid nanoparticle by siRNA market, 2018 - 2030 (USD Million)
  • Fig. 27 Global lipid nanoparticle by mRNA market, 2018 - 2030 (USD Million)
  • Fig. 28 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
  • Fig. 29 Lipid nanoparticle market: Application outlook and key takeaways
  • Fig. 30 Lipid nanoparticle market: Application market share analysis, 2023-2030
  • Fig. 31 Global lipid nanoparticle by therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 32 Global lipid nanoparticle by research market, 2018 - 2030 (USD Million)
  • Fig. 33 Lipid nanoparticle market: Indication outlook and key takeaways
  • Fig. 34 Lipid nanoparticle market: Indication market share analysis, 2023-2030
  • Fig. 35 Global lipid nanoparticle by cancer market, 2018 - 2030 (USD Million)
  • Fig. 36 Global lipid nanoparticle by infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 37 Global lipid nanoparticle by blood diseases market, 2018 - 2030 (USD Million)
  • Fig. 38 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
  • Fig. 39 Lipid nanoparticle market: End user outlook and key takeaways
  • Fig. 40 Lipid nanoparticle market: end user market share analysis, 2023-2030
  • Fig. 41 Global lipid nanoparticle by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 42 Global lipid nanoparticle by academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 43 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. key country dynamics
  • Fig. 47 U.S. lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Canada key country dynamics
  • Fig. 49 Canada lipid nanoparticle market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico key country dynamics
  • Fig. 51 Mexico lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 52 Europe lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 53 UK key country dynamics
  • Fig. 54 UK lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 55 Germany key country dynamics
  • Fig. 56 Germany lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 57 France key country dynamics
  • Fig. 58 France lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 59 Italy key country dynamics
  • Fig. 60 Italy lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 61 Spain key country dynamics
  • Fig. 62 Spain lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 63 Denmark key country dynamics
  • Fig. 64 Denmark lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 65 Sweden key country dynamics
  • Fig. 66 Sweden lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 67 Norway key country dynamics
  • Fig. 68 Norway lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 69 Asia-Pacific lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 70 Japan key country dynamics
  • Fig. 71 Japan lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 72 China key country dynamics
  • Fig. 73 China lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 74 India key country dynamics
  • Fig. 75 India lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 76 Australia key country dynamics
  • Fig. 77 Australia lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 78 Thailand key country dynamics
  • Fig. 79 Thailand lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 80 South Korea key country dynamics
  • Fig. 81 South Korea lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 82 Latin America lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 83 Brazil key country dynamics
  • Fig. 84 Brazil lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 85 Argentina key country dynamics
  • Fig. 86 Argentina lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 87 MEA lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 88 South Africa key country dynamics
  • Fig. 89 South Africa lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 90 Saudi Arabia key country dynamics
  • Fig. 91 Saudi Arabia lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 92 UAE key country dynamics
  • Fig. 93 UAE lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 94 Kuwait key country dynamics
  • Fig. 95 Kuwait lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 96 Key company categorization
  • Fig. 97 Company market positioning
  • Fig. 98 Market participant categorization
  • Fig. 99 Strategy framework